The pharmacokinetics of methadone in HIV-positive patients receiving the non-nucleoside reverse transcriptase inhibitor efavirenz

British Journal of Clinical Pharmacology

Volumn 51, Issue 3, 2001, Pages 213-217

  Clarke, Susan M ^a,b   Mulcahy, Fiona M ^a,b   Tjia, John ^b   Reynolds, Helen E ^b   Gibbons, Sara E ^b   Barry, Michael G ^a,b   Back, David J ^b  

^a ST JAMES S HOSPITAL   (Ireland)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Efavirenz; HIV; Methadone

Indexed keywords

CYTOCHROME P450 3A4; EFAVIRENZ; METHADONE; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG WITHDRAWAL; ENZYME INDUCTION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; MALE; PRIORITY JOURNAL; STEADY STATE; TEMPERATURE DEPENDENCE;

ADULT; ANALGESICS, OPIOID; DRUG INTERACTIONS; FEMALE; HIV INFECTIONS; HUMANS; MALE; METHADONE; OXAZINES; REVERSE TRANSCRIPTASE INHIBITORS; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0035034313     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.2001.00342.x     Document Type: Article

References (25)

1. Effective medical treatment of opiate addiction
2. Barriers to use of free antiretroviral therapy in injection drug users
3. Self reported antiretroviral therapy in injection drug users
4. Updated recommendations of the International AIDS Society-USA Panel - Antiretroviral therapy for HIV infection in 1998
5. Nevirapine induced opiate withdrawal among injection drug users with HIV infection receiving methadone
6. Nevirapine induced withdrawal symptoms in HIV patients on methadone maintenance programmes -an alert
7. Prevalence and patterns of concomitant medications among participants in 3 multicentre HIV type 1 clinical trials
8. Pharmacokinetics and potential interactions amongst antiretroviral agents used to treat HIV infection
9. Involvement of cytochrome P450 3A4 enzyme in the N-demethylation of methadone in human liver microsomes
10. Methadone N-oxide in the urine of methadone maintained subjects
11. The effects of fluconazole on the clinical pharmacokinetics of methadone
12. Phenytoin-induced methadone withdrawal
13. Valproic acid-unlike other anticonvulsants has no effect on methadone metabolism: 2 cases
14. Rifampicin-induced methadone withdrawal
15. Rifampin drug interactions
16. Methadone maintenance and tuberculosis treatment
17. Rifampicin induced methadone in AIDS
18. High dose nevirapine: Safety, pharmacokinetics, and antiviral effect in patients with HIV infection
19. Efavirenz
20. Enzyme induction and inhibition
21. Methadone toxicity causing death in 10 subjects starting on a methadone maintenance programme
22. Methadone: One person's maintenance dose is another's poison
23. A physiological approach to hepatic drug clearance
24. Integration with kinetics